Pharmacokinetics and toxicodynamics of oxaliplatin in rats: application of a toxicity factor to explain differences in the nephrotoxicity and myelosuppression induced by oxaliplatin and the other platinum antitumor derivatives. [electronic resource]
- Pharmaceutical research Sep 2010
- 1893-9 p. digital
Publication Type: Journal Article
1573-904X
10.1007/s11095-010-0189-4 doi
Animals Antineoplastic Agents--pharmacokinetics Area Under Curve Blood Urea Nitrogen Bone Marrow--drug effects Dose-Response Relationship, Drug Drug Stability Hydrolysis Infusions, Intravenous Injections, Intravenous Kidney--drug effects Male Metabolic Clearance Rate Models, Biological Molecular Structure Organoplatinum Compounds--pharmacokinetics Oxaliplatin Platelet Count Rats Rats, Wistar Time Factors Tissue Distribution